# | Title | Journal | Year | Citations |
---|
1 | The Cytochrome P450 Superfamily: Biochemistry, Evolution and Drug Metabolism in Humans | Current Drug Metabolism | 2002 | 644 |
2 | Neopterin as a Marker for Immune System Activation | Current Drug Metabolism | 2002 | 634 |
3 | A Comprehensive Listing of Bioactivation Pathways of Organic Functional Groups | Current Drug Metabolism | 2005 | 592 |
4 | Drugs Behave as Substrates, Inhibitors and Inducers of Human Cytochrome P450 3A4 | Current Drug Metabolism | 2008 | 550 |
5 | Tyrosine Kinase Inhibitors – A Review on Pharmacology, Metabolism and Side Effects | Current Drug Metabolism | 2009 | 510 |
6 | (Section A: Molecular, Structural, and Cellular Biology of Drug Transporters) The MRP-Related and BCRP / ABCG2 Multidrug Resistance Proteins: Biology, Substrate Specificity and Regulation | Current Drug Metabolism | 2004 | 469 |
7 | UDP-Glucuronosyltransferases | Current Drug Metabolism | 2000 | 431 |
8 | Scaling Factors for the Extrapolation of In Vivo Metabolic Drug Clearance From In Vitro Data: Reaching a Consensus on Values of Human Micro-somal Protein and Hepatocellularity Per Gram of Liver | Current Drug Metabolism | 2007 | 398 |
9 | Medicinal Plants and Cancer Chemoprevention | Current Drug Metabolism | 2008 | 383 |
10 | Pharmacogenomics, Regulation and Signaling Pathways of Phase I and II Drug Metabolizing Enzymes | Current Drug Metabolism | 2002 | 382 |
11 | Isothiocyanates as Cancer Chemopreventive Agents: Their Biological Activities and Metabolism in Rodents and Humans | Current Drug Metabolism | 2002 | 365 |
12 | Incorporation of Pharmacogenomics into Routine Clinical Practice: the Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline Development Process | Current Drug Metabolism | 2014 | 341 |
13 | Selective Serotonin Reuptake Inhibitors and Cytochrome P-450 Mediated Drug-Drug Interactions: An Update | Current Drug Metabolism | 2002 | 334 |
14 | PEGylation of Proteins and Liposomes: a Powerful and Flexible Strategy to Improve the Drug Delivery | Current Drug Metabolism | 2012 | 334 |
15 | Prediction of Intestinal First-Pass Drug Metabolism | Current Drug Metabolism | 2007 | 329 |
16 | Design of Ester Prodrugs to Enhance Oral Absorption of Poorly Permeable Compounds: Challenges to the Discovery Scientist | Current Drug Metabolism | 2003 | 303 |
17 | A Microscale In Vitro Physiological Model of the Liver: Predictive Screens for Drug Metabolism and Enzyme Induction | Current Drug Metabolism | 2005 | 292 |
18 | Xenobiotic-Induced Transcriptional Regulation of Xenobiotic Metabolizing Enzymes of the Cytochrome P450 Superfamily in Human Extrahepatic Tissues | Current Drug Metabolism | 2008 | 289 |
19 | The Metabolism and Toxicity of Quinones, Quinonimines, Quinone Methides, and Quinone-Thioethers | Current Drug Metabolism | 2002 | 271 |
20 | CYP2B6: New Insights into a Historically Overlooked Cytochrome P450 Isozyme | Current Drug Metabolism | 2008 | 264 |
21 | Metabolism of Green Tea Catechins: An Overview | Current Drug Metabolism | 2006 | 261 |
22 | Cell Lines: A Tool for In Vitro Drug Metabolism Studies | Current Drug Metabolism | 2008 | 259 |
23 | Evolutionary Advantage and Molecular Modes of Action of Multi-Component Mixtures Used in Phytomedicine | Current Drug Metabolism | 2008 | 259 |
24 | Cytochrome P450 Gene Polymorphism and Cancer | Current Drug Metabolism | 2004 | 257 |
25 | Relevance of the Deletion Polymorphisms of the Glutathione S-Transferases GSTT1 and GSTM1 in Pharmacology and Toxicology | Current Drug Metabolism | 2006 | 256 |
26 | Molecular Mechanisms Underlying the Dedifferentiation Process of Isolated Hepatocytes and Their Cultures | Current Drug Metabolism | 2006 | 253 |
27 | Preclinical Pharmacokinetics: An Approach Towards Safer and Efficacious Drugs | Current Drug Metabolism | 2006 | 240 |
28 | Mechanism-Based Inactivation of Cytochrome P450 Enzymes: Chemical Mechanisms, Structure-Activity Relationships and Relationship to Clinical Drug-Drug Interactions and Idiosyncratic Adverse Drug Reactions | Current Drug Metabolism | 2007 | 238 |
29 | Essential Oils: Extraction Techniques, Pharmaceutical And Therapeutic Potential - A Review | Current Drug Metabolism | 2018 | 236 |
30 | Chronic Immune Stimulation Correlates with Reduced Phenylalanine Turnover | Current Drug Metabolism | 2008 | 235 |
31 | The Conduct of Drug Metabolism Studies Considered Good Practice (II): In Vitro Experiments | Current Drug Metabolism | 2007 | 234 |
32 | Human Hepatocytes in Primary Culture: The Choice to Investigate Drug Metabolism in Man | Current Drug Metabolism | 2004 | 227 |
33 | (Section A: Molecular, Structural, and Cellular Biology of Drug Transporters) Mammalian Nucleoside Transporters | Current Drug Metabolism | 2004 | 227 |
34 | Structure and Function of the Human Breast Cancer Resistance Protein (BCRP/ABCG2) | Current Drug Metabolism | 2010 | 225 |
35 | Age-Related Changes in Pharmacokinetics | Current Drug Metabolism | 2011 | 223 |
36 | Zebrafish: A Complete Animal Model for In Vivo Drug Discovery and Development | Current Drug Metabolism | 2009 | 221 |
37 | Catechol-O-Methyltransferase (COMT)-Mediated Methylation Metabolism of Endogenous Bioactive Catechols and Modulation by Endobiotics and Xenobiotics: Importance in Pathophysiology and Pathogenesis | Current Drug Metabolism | 2002 | 220 |
38 | Cytochrome P450 Turnover: Regulation of Synthesis and Degradation, Methods for Determining Rates, and Implications for the Prediction of Drug Interactions | Current Drug Metabolism | 2008 | 220 |
39 | Cancer Nanotechnology: A New Revolution for Cancer Diagnosis and Therapy | Current Drug Metabolism | 2019 | 220 |
40 | L-Carnitine - Metabolic Functions and Meaning in Humans Life | Current Drug Metabolism | 2011 | 217 |
41 | Induction of CYP1A1. The AhR / DRE Paradigm Transcription, Receptor Regulation, and Expanding Biological Roles | Current Drug Metabolism | 2001 | 211 |
42 | Drug-Metabolizing Enzymes Mechanisms and Functions | Current Drug Metabolism | 2000 | 206 |
43 | Human Hepatocytes as a Tool for Studying Toxicity and Drug Metabolism | Current Drug Metabolism | 2003 | 206 |
44 | Drug Uptake Systems in Liver and Kidney | Current Drug Metabolism | 2003 | 206 |
45 | The Metabolism of Diclofenac - Enzymology and Toxicology Perspectives | Current Drug Metabolism | 2003 | 206 |
46 | Cannabinoids and Cytochrome P450 Interactions | Current Drug Metabolism | 2016 | 205 |
47 | Use of Non-steroidal Anti-inflammatory Drugs in Pregnancy: Impact on the Fetus and Newborn | Current Drug Metabolism | 2012 | 203 |
48 | Clinical Pharmacogenetics and Potential Application in Personalized Medicine | Current Drug Metabolism | 2008 | 196 |
49 | Therapeutic Nanoparticles to Combat Cancer Drug Resistance | Current Drug Metabolism | 2009 | 196 |
50 | Retinoic Acid Metabolism and Mechanism of Action: A Review | Current Drug Metabolism | 2003 | 195 |